PATENT CLAIM ANALYSIS

Application Number: 15879052
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure provides compositions and methods for improving the efficacy of enzyme replacement therapy for lysosomal storage diseases.

Claim (Index 3):
The method according to  claim 1 , wherein the therapeutic candidate is selected from the group consisting of double stranded RNA, antisense oligonucleotides (ASO), small interfering RNA (siRNA), short hairpin RNA (shRNA), microRNA (miRNAs) oligonucleotides, and small molecule drugs.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.05263
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13391265', '13253005', '12801404', '14936568', '15438375']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7918759483817206
- 35 USC 102 Novelty (BERT): 0.5024150624047901
- Combined Prediction Score: 0.7629298597840275
- Mean Citation Score: 234.578618
- Max Citation Score: 247.39505
- Similarity Product: 169.79572617048026

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test